Abstract
Natural killer T (NKT) cells are among the immediate and early responding immune cells and are important players in autoimmune diseases and tumor immunity. This unique subset of T cells shares properties of natural killer cells and T cells. Proper identification and characterization of NKT cell subsets is essential to understand the function and involvement of these understudied immune cells in various diseases. This review aims to summarize the known methods for identifying and characterizing NKT cells. NKT cells are divided into Type I (or invariant) and Type II, with either limited or broad TCR repertoires, respectively, that generally respond to glycolipids presented on the nonclassical MHC, CD1d. Type I NKT cells or invariant NKT cells (iNKT) are the most well studied and can be further subdivided into NKT1, NKT2, or NKT17 populations, classified based on their functional capacity. Conversely, less is known about Type II NKT cells because they have a more diverse TCR repertoire which make them hard to identify. However, genetic analyses have shed light on the development and function of all NKT subsets, which aids in their characterization. Further exploration of the role of NKT cells in various diseases will reveal the intricacies and importance of their novel functions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Godfrey D, Hammond K, Poulton L, Smyth M, Baxter A (2000) NKT cells: facts, functions and fallacies. Immunol Today 21:573–583
Berzins S, Uldrich A, Pellicci D, McNab F, Kayakawa Y, Smyth M, Godfrey D (2004) Parallels and distinctions between T and NKT cell development in the thymus. Immunol Cell Biol 82:269–275
Emoto M, Kaufmann S (2003) Liver NKT cells: an account of heterogeneity. Trends Immunol 24:364–369
Zhou D, Mattner J, Cantu C 3rd, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu Y et al (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306:1786–1789
Hansen D, Schofield L (2004) Regulation of immunity and pathogenesis in infectious diseases by CD1d-restricted NKT cells. Int J Parasitol 34(1):15–25
Crowe N, Uldrich A, Kyparissoudis K, Hammond K, Hayakawa Y, Sidobre S, Keating R, Kronenberg M, Smyth M, Godfrey D (2003) Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J Immunol 171(8):4020–4027
Gadue P, Stein P (2002) NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J Immunol 169:2397–2406
Stenstrom M, Skold M, Ericsson A, Beaudoin L, Sidobre S, Kronenberg M, Leheren A, Cardell S (2004) Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type. Eur J Immunol 34:56–65
Gumperz J, Miyake S, Yamamura T, Brenner M (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195:625–636
Pellicci D, Hammond K, Uldrich A, Baxter A, Smyth M, Godfrey D (2002) A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(−)CD4(+) CD1d-dependent precursor stage. J Exp Med 195:835–844
Godfrey D, Stankovic S, Baxter A (2010) Raising the NKT cell family. Nat Immunol 11:197–206
Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, Koseki H, Kanno M, Taniguchi M (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623–1626
Jordan M, Fletcher J, Baxter A (2004) Genetic control of NKT cell numbers. Immunol Cell Biol 82:276–284
Griewank K, Borowski C, Rietdijk S, Wang N, Julien A, Wei D, Mamchak A, Terhorst C, Bendelac A (2007) Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27:751–762
D’Cruz LM, Stradner MH, Yang CY, Goldrath AW (2014) E and Id proteins influence invariant NKT cell sublineage differentiation and proliferation. J Immunol 192(5):2227–2236
Verykokakis M, Krishnamoorthy V, Iavarone A, Lasorella A, Sigvardsson M, Kee BL (2013) Essential functions for ID proteins at multiple checkpoints in invariant NKT cell development. J Immunol 191(12):5973–5983
Thapa P, Das J, McWilliams D, Shapiro M, Sundsbak R, Nelson-Holte M, Tangen S, Anderson J, Desiderio S, Hiebert S, Sant’angelo DB, Shapiro VS (2013) The transcriptional repressor NKAP is required for the development of iNKT cells. Nat Commun 4:1582
White AJ, Lucas B, Jenkinson WE, Anderson G (2018) Invariant NKT cells and control of the thymus medulla. J Immunol 200(10):3333–3339
Godfrey DI, Berzins SP (2007) Control points in NKT-cell development. Nat Rev Immunol 7(7):505–518
Krovi SH, Gapin L (2018) Invariant natural killer T cell subsets-more than just developmental intermediates. Front Immunol 9:1393
Seiler MP, Mathew R, Liszewski MK, Spooner CJ, Spooner C, Barr K, Meng F, Singh H, Bendelac A (2012) Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling. Nat Immunol 13(3):264–271
Lazarevic V, Zullo AJ, Schweitzer MN, Staton TL, Gallo EM, Crabtree GR, Glimcher LH (2009) The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat Immunol 10(3):306–313
Kumar A, Suryadevara N, Hill TM, Bezbradica JS, Van Kaer L, Joyce S (2017) Natural killer T cells: an ecological evolutionary developmental biology perspective. Front Immunol 8:1858
Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, Alonzo E, Chua K, Eidson M, Kim HJ, Im JS, Pandolfi PP, Sant’Angelo DB (2008) The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol 9(9):1055–1064
Savage AK, Constantinides MG, Han J, Picard D, Martin E, Li B, Lantz O, Bendelac A (2008) The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29(3):391–403
Kwon DI, Lee YJ (2017) Lineage differentiation program of invariant natural killer T cells. Immune Network 17(6):365–377
Constantinides MG, Bendelac A (2013) Transcriptional regulation of the NKT cell lineage. Curr Opin Immunol 25(2):161–167
Shissler SC, Webb TJ (2019) The ins and outs of type I iNKT cell development. Mol Immunol 105:116–130
Watarai H, Sekine-Kondo E, Shigeura T, Motomura Y, Yasuda T, Satoh R, Yoshida H, Kubo M, Kawamoto H, Koseki H, Taniguchi M (2012) Development and function of invariant natural killer T cells producing T(h)2- and T(h)17-cytokines. PLoS Biol 10(2):e1001255
Wang H, Hogquist KA (2018) How lipid-specific T cells become effectors: the differentiation of iNKT subsets. Front Immunol 9:1450
Li J, Wu D, Jiang N, Zhuang Y (2013) Combined deletion of Id2 and Id3 genes reveals multiple roles for E proteins in invariant NKT cell development and expansion. J Immunol 191(10):5052–5064
Wang L, Carr T, Xiong Y, Wildt KF, Zhu J, Feigenbaum L, Bendelac A, Bosselut R (2010) The sequential activity of Gata3 and Thpok is required for the differentiation of CD1d-restricted CD4+ NKT cells. Eur J Immunol 40(9):2385–2390
Thapa P, Romero Arocha S, Chung JY, Sant’Angelo DB, Shapiro VS (2017) Histone deacetylase 3 is required for iNKT cell development. Sci Rep 7(1):5784
O’Hagan KL, Zhao J, Pryshchep O, Wang CR, Phee H (2015) Pak2 controls acquisition of NKT cell fate by regulating expression of the transcription factors PLZF and Egr2. J Immunol 195(11):5272–5284
Carr T, Krishnamoorthy V, Yu S, Xue HH, Kee BL, Verykokakis M (2015) The transcription factor lymphoid enhancer factor 1 controls invariant natural killer T cell expansion and Th2-type effector differentiation. J Exp Med 212(5):793–807
Gapin L (2016) Development of invariant natural killer T cells. Curr Opin Immunol 39:68–74
Cardell S, Tangri S, Chan S, Kronenberg M, Benoist C, Mathis D (1995) CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. J Exp Med 182(4):993–1004
Park SH, Weiss A, Benlagha K, Kyin T, Teyton L, Bendelac A (2001) The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families. J Exp Med 193(8):893–904
Genardi S, Visvabharathy L, Cao L, Morgun E, Cui Y, Qi C, Chen YH, Gapin L, Berdyshev E, Wang CR (2020) Type II natural killer T cells contribute to protection against systemic methicillin-resistant Staphylococcus aureus infection. Front Immunol 11:610010
Rhost S, Löfbom L, Rynmark BM, Pei B, Månsson JE, Teneberg S, Blomqvist M, Cardell SL (2012) Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte. Eur J Immunol 42(11):2851–2860
Tatituri RV, Watts GF, Bhowruth V, Barton N, Rothchild A, Hsu FF, Almeida CF, Cox LR, Eggeling L, Cardell S, Rossjohn J, Godfrey DI, Behar SM, Besra GS, Brenner MB, Brigl M (2013) Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs. Proc Natl Acad Sci U S A 110(5):1827–1832
Zhao J, Weng X, Bagchi S, Wang CR (2014) Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response. Proc Natl Acad Sci U S A 111(7):2674–2679
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sahler, J., Anannya, O., Limper, C., Imbiakha, B., Pierpont, T., August, A. (2021). Genetic Analysis of iNKT Cell Development and Function. In: Liu, C. (eds) Invariant Natural Killer T-Cells. Methods in Molecular Biology, vol 2388. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1775-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1775-5_1
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1774-8
Online ISBN: 978-1-0716-1775-5
eBook Packages: Springer Protocols